http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104530046-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0152623cff45c7c58e9c47b65ea4ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
filingDate 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6960661ea8155cc490572dc399b038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db8b98512c6b2b413b63c66c554c5ec3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e2c45541469c2bd8c05db0b5d4b5df5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f347195b7948c0f0e5ddc09f49232f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8f5acb45c5b5d41595d95146c2651c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7faf31516e0ff0dd042bc519c458f1e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85ba23e8f0634fe8332daa084baab26a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1060d3c586596e3e56fd084b95152ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bfab18400379436d1f08e2303030e91
publicationDate 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104530046-A
titleOfInvention Diazaspiro compounds and their application in medicine
abstract The present invention relates to a novel diaza spiro compound, or its stereoisomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salt or prodrug. The present invention also relates to diaza spiro compounds or their stereoisomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs Use as a medicament, especially as a medicament for the preparation of factor Xa inhibitors.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022057928-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113544130-A
priorityDate 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013186159-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164007579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465008633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141390944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465802439

Total number of triples: 33.